254 related articles for article (PubMed ID: 7503087)
1. The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women.
Grey AB; Stapleton JP; Evans MC; Tatnell MA; Ames RW; Reid IR
Am J Med; 1995 Dec; 99(6):636-41. PubMed ID: 7503087
[TBL] [Abstract][Full Text] [Related]
2. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women.
Ward RL; Morgan G; Dalley D; Kelly PJ
Bone Miner; 1993 Aug; 22(2):87-94. PubMed ID: 8251768
[TBL] [Abstract][Full Text] [Related]
4. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
[TBL] [Abstract][Full Text] [Related]
5. Effect of Milk Powder Supplementation with Different Calcium Contents on Bone Mineral Density of Postmenopausal Women in Northern China: A Randomized Controlled Double-Blind Trial.
Chen Y; Xiao Y; Xie B; Zhang Q; Ma X; Li N; Liu M; Zhang Q
Calcif Tissue Int; 2016 Jan; 98(1):60-6. PubMed ID: 26438518
[TBL] [Abstract][Full Text] [Related]
6. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial.
Reid IR; Ames RW; Orr-Walker BJ; Clearwater JM; Horne AM; Evans MC; Murray MA; McNeil AR; Gamble GD
Am J Med; 2000 Oct; 109(5):362-70. PubMed ID: 11020392
[TBL] [Abstract][Full Text] [Related]
7. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
Marttunen MB; Hietanen P; Tiitinen A; Ylikorkala O
J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
[TBL] [Abstract][Full Text] [Related]
8. Effects on bone mass after eight years of hormonal replacement therapy.
Eiken P; Nielsen SP; Kolthoff N
Br J Obstet Gynaecol; 1997 Jun; 104(6):702-7. PubMed ID: 9197874
[TBL] [Abstract][Full Text] [Related]
9. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
Powles TJ; Hickish T; Kanis JA; Tidy A; Ashley S
J Clin Oncol; 1996 Jan; 14(1):78-84. PubMed ID: 8558225
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study.
Kristensen B; Ejlertsen B; Dalgaard P; Larsen L; Holmegaard SN; Transbøl I; Mouridsen HT
J Clin Oncol; 1994 May; 12(5):992-7. PubMed ID: 8164053
[TBL] [Abstract][Full Text] [Related]
11. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
12. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
[TBL] [Abstract][Full Text] [Related]
13. [Bone mineral density of the femoral neck, a cross-sectional study of normal values in 827 French women aged 36 to 86 years].
Tsouderos Y; Bauza-Canellas C; Decassin P; Denis M; Cusset B; Audrain S
Rev Rhum Ed Fr; 1994 Jun; 61(6):439-46. PubMed ID: 7833869
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study.
Delmas PD; Balena R; Confravreux E; Hardouin C; Hardy P; Bremond A
J Clin Oncol; 1997 Mar; 15(3):955-62. PubMed ID: 9060533
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation and bone mineral density in early postmenopausal women.
Cooper L; Clifton-Bligh PB; Nery ML; Figtree G; Twigg S; Hibbert E; Robinson BG
Am J Clin Nutr; 2003 May; 77(5):1324-9. PubMed ID: 12716689
[TBL] [Abstract][Full Text] [Related]
16. Effect of calcium supplementation on bone loss in postmenopausal women.
Reid IR; Ames RW; Evans MC; Gamble GD; Sharpe SJ
N Engl J Med; 1993 Feb; 328(7):460-4. PubMed ID: 8421475
[TBL] [Abstract][Full Text] [Related]
17. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.
Love RR; Mazess RB; Barden HS; Epstein S; Newcomb PA; Jordan VC; Carbone PP; DeMets DL
N Engl J Med; 1992 Mar; 326(13):852-6. PubMed ID: 1542321
[TBL] [Abstract][Full Text] [Related]
18. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years.
Love RR; Barden HS; Mazess RB; Epstein S; Chappell RJ
Arch Intern Med; 1994 Nov; 154(22):2585-8. PubMed ID: 7979855
[TBL] [Abstract][Full Text] [Related]
19. Body Mass Index May Positively Correlate with Bone Mineral Density of Lumbar Vertebra and Femoral Neck in Postmenopausal Females.
Wu SF; Du XJ
Med Sci Monit; 2016 Jan; 22():145-51. PubMed ID: 26766815
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
